scholarly article | Q13442814 |
P50 | author | Kenneth Blum | Q6389872 |
Rajendra Badgaiyan | Q19938391 | ||
James L Fratantonio | Q114407804 | ||
Mary Hauser | Q114407813 | ||
P2860 | cites work | The genetic basis of addictive disorders | Q24607129 |
Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS) | Q28652508 | ||
Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials | Q31138857 | ||
The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction | Q33579769 | ||
Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch. | Q33609822 | ||
Genetic risk prediction and neurobiological understanding of alcoholism | Q33672725 | ||
Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric. | Q34304684 | ||
Allelic association of human dopamine D2 receptor gene in alcoholism | Q34998499 | ||
Genetic influence of dopamine receptor, dopamine transporter, and nicotine metabolism on smoking cessation and nicotine dependence in a Japanese population | Q35016329 | ||
Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)? | Q35053937 | ||
Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence | Q35085081 | ||
Transcriptome organization for chronic alcohol abuse in human brain. | Q35674997 | ||
Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward | Q36234280 | ||
Pharmacogenetics of opioid receptors and addiction | Q36339767 | ||
Using genetic information from candidate gene and genome-wide association studies in risk prediction for alcohol dependence | Q36876237 | ||
Gene x abstinence effects on drug cue reactivity in addiction: multimodal evidence | Q36928468 | ||
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts | Q37164595 | ||
Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood | Q37280300 | ||
Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring | Q37876422 | ||
Alterations in brain connectivity in three sub-regions of the anterior cingulate cortex in heroin-dependent individuals: Evidence from resting state fMRI. | Q39090343 | ||
The D2 dopamine receptor gene as a predictor of compulsive disease: Bayes' theorem | Q40468073 | ||
The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. | Q40575056 | ||
Candidate genes in alcoholism. | Q40976810 | ||
Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial | Q44626401 | ||
Neurocognitive variation in smoking behavior and withdrawal: genetic and affective moderators | Q45285800 | ||
Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disorders | Q46287440 | ||
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. | Q52275787 | ||
The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. | Q55331780 | ||
Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse Treatment | Q60682780 | ||
Association between the D2 dopamine receptor gene and alcoholism. A continuing controversy | Q67961284 | ||
What can the DRD2/alcoholism story teach us about association studies in psychiatric genetics? | Q71552324 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P304 | page(s) | 1-5 | |
P577 | publication date | 2015-07-01 | |
P1433 | published in | Addiction genetics | Q27725310 |
P1476 | title | Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility | |
P478 | volume | 2 |
Search more.